Skip to main content

Table 2 Clinical presentation between ESBL-positive EcBSI and ESBL-negative EcBSI

From: Risk factor analysis for extended-spectrum β-lactamase-producing Enterobacter cloacaebloodstream infections in central Taiwan

   ESBL(−) ESBL(+) P-value
  Integron(−) Integron(+)    Integron(−) Integron(+)   
   Total N % N % P-value Total N % N % P-value  
Sex Male 29 9 31.0 20 69.0 0.851 8 2 25.0 6 75.0 1.000 1.000
Female 21 6 28.6 15 71.4   12 4 33.3 8 66.7   1.000
Previous antibiotics at the empirical stage before No 24 1 5.0 23 95.0 1.000 17 7 41.2 10 58.8 1.000 0.023
E. cloacae infection Yes 26 16 61.0 10 39.0   3 1 33.3 2 66.7   
Prognosis Survival 38 18 47.4 20 52.6 0.874 8 2 25.0 6 75.0 1.000 0.435
Expired 12 6 50.0 6 50.0   12 2 16.7 10 83.3   0.193
Type of infection Primary 1 0 0.0 1 100.0 1.000 5 2 0.0 3 100.0 1.000  
Secondary 49 9 18.4 40 81.6   15 4 21.1 11 78.9   1.000
Secondary infection (multiple) Total 49 19   30    15 5   10    
Respiratory tract 30 10 33.3 20 66.7 0.326 3 1 33.3 2 66.7 0.370 1.000
Urinary tract 12 2 16.7 10 83.3 0.095 6 1   5   0.023 1.000
Catheter-related 2 0 0.0 2 100.0 0.515 0 0 0.0 0 100.0 1.000  
Intra-abdominal infection 9 2 22.2 7 77.8 0.451 6 0 0.0 6 100.0 0.474 1.000
CNS infection 3 1 33.3 2 66.7 1.000 0 0 0.0 0 0.0   
  Others 3 1 33.3 2 66.7 1.000 0 0 0.0 0 00 0.474 1.000
  1. P-value by chi-squared test or Fisher’s exact test when appropriate.